SAFETY OF SGLT2 INHIBITORS (SGLT2I) IN PEOPLE OVER 75 YEARS

被引：0

作者：

Marques Vidas, Maria ^{[1
]}

Domenech, Ester ^{[1
]}

Martin Testillano, Lucia ^{[1
]}

Maroto, Alba ^{[1
]}

Lopez, Paula ^{[1
]}

Portoles, Jose' M. ^{[1
]}

机构：

[1] Puerta de Hierro Univ Hosp, Dept Nephrol, Majadahonda, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

MO167

引用

页码：I104 / I104

页数：1

共 50 条

[31] SGLT2 inhibitors in people with and without T2DM
Kamlesh Khunti
Nature Reviews Endocrinology, 2021, 17 : 75 - 76
[32] Turning Glucosuria into a Therapy: Efficacy and Safety with SGLT2 Inhibitors
Patel, Anupa K.
Fonseca, Vivian
CURRENT DIABETES REPORTS, 2010, 10 (02) : 101 - 107
[33] SGLT2 Inhibitors for Type 2 Diabetes
Liu, Jiwen
Lee, TaeWeon
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
[34] Fournier gangrene: new safety concern of SGLT2 inhibitors
Reactions Weekly, 2019, 1753 (1) : 8 - 8
[35] SGLT2 inhibitors for heart and kidney
van der Giet, Markus
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
[36] SGLT2 Inhibitors and Mechanisms of Hypertension
Briasoulis, Alexandros
Al Dhaybi, Omar
Bakris, George L.
CURRENT CARDIOLOGY REPORTS, 2018, 20 (01)
[37] SGLT2 inhibitors in diabetes with CKD
Malik, A. H.
Yandrapalli, S.
Goldberg, M.
Jain, D.
Frishman, W. H.
Aronow, W. S.
EUROPEAN HEART JOURNAL, 2019, 40 : 1448 - 1448
[38] SGLT2 Inhibitors: Mind the Gap
Jiang, Chuan
Palkar, Atul
Caronia, Jonathan
Gottesman, Eric
CHEST, 2016, 150 (04) : 266A - 266A
[39] SGLT2 Inhibitors: Physiology and Pharmacology
Wright, Ernest M.
KIDNEY360, 2021, 2 (12): : 2027 - 2037
[40] The expanding resume of SGLT2 inhibitors
de Boer, Ian H.
LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (08): : 585 - 587